Alin Stirban

Summary

Country: Germany

Publications

  1. ncbi Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus
    Alin Stirban
    Ruhr University Bochum, Bochum, Germany
    Am J Clin Nutr 91:808-13. 2010
  2. ncbi [The role of AGEs and ROS in atherosclerosis]
    Alin Stirban
    Diabetesklinik, Herz und Diabeteszentrum NRW, Ruhr Universitat Bochum, Bad Oeynhausen, Germany
    Herz 35:170-80. 2010
  3. ncbi Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines
    Alin Stirban
    Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Germany
    Ann N Y Acad Sci 1126:276-9. 2008
  4. ncbi Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus
    Monica Negrean
    Diabetes Clinic, Heart and Diabetes Centre NRW Bad Oeynhausen, Ruhr University Bochum, Germany
    Am J Clin Nutr 85:1236-43. 2007
  5. ncbi Skin autofluorescence increases postprandially in human subjects
    Alin Stirban
    Diabetes Center, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany
    Diabetes Technol Ther 10:200-5. 2008
  6. ncbi Complications of type 1 diabetes: new molecular findings
    Alin Stirban
    Diabetes Clinic, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
    Mt Sinai J Med 75:328-51. 2008
  7. ncbi Drugs for the treatment of diabetes complications. Zycose: a new player in the field?
    Alin Stirban
    Diabetes Clinic at the Heart and Diabetes Center North Rhine Westphalia Ruhr University Bochum, Bad Oeynhausen, Germany
    Drugs Today (Barc) 44:783-96. 2008

Collaborators

Detail Information

Publications7

  1. ncbi Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus
    Alin Stirban
    Ruhr University Bochum, Bochum, Germany
    Am J Clin Nutr 91:808-13. 2010
    ..Recent evidence supports the protective effects of n-3 (omega-3) fatty acids (n-3 FAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on vascular function...
  2. ncbi [The role of AGEs and ROS in atherosclerosis]
    Alin Stirban
    Diabetesklinik, Herz und Diabeteszentrum NRW, Ruhr Universitat Bochum, Bad Oeynhausen, Germany
    Herz 35:170-80. 2010
    ....
  3. ncbi Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines
    Alin Stirban
    Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Germany
    Ann N Y Acad Sci 1126:276-9. 2008
    ..The postprandial excursions in glucose, insulin, and triglycerides were similar between both meals. A meal rich in AGEs induces acute endothelial and adipocyte dysfunction. These effects were prevented by changing the cooking method...
  4. ncbi Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus
    Monica Negrean
    Diabetes Clinic, Heart and Diabetes Centre NRW Bad Oeynhausen, Ruhr University Bochum, Germany
    Am J Clin Nutr 85:1236-43. 2007
    ..An advanced glycation endproducts (AGEs)-rich diet induces significant increases in inflammatory and endothelial dysfunction markers in type 2 diabetes mellitus (T2DM)...
  5. ncbi Skin autofluorescence increases postprandially in human subjects
    Alin Stirban
    Diabetes Center, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany
    Diabetes Technol Ther 10:200-5. 2008
    ..It has also been suggested that SAF measurement is independent of fasting status. Our study was designed in order to test whether SAF changes postprandially...
  6. ncbi Complications of type 1 diabetes: new molecular findings
    Alin Stirban
    Diabetes Clinic, Heart and Diabetes Center North Rhine Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
    Mt Sinai J Med 75:328-51. 2008
    ..Therefore, our purpose is to present the most relevant concepts underlying diabetic complications in an attempt to contribute to a better understanding and pinpoint areas that warrant further research...
  7. ncbi Drugs for the treatment of diabetes complications. Zycose: a new player in the field?
    Alin Stirban
    Diabetes Clinic at the Heart and Diabetes Center North Rhine Westphalia Ruhr University Bochum, Bad Oeynhausen, Germany
    Drugs Today (Barc) 44:783-96. 2008
    ..The compound consists mainly of vitamins, therefore explaining, in part, the good safety profile and reduced adverse effects...